UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000026214
Receipt number R000030114
Scientific Title The study to explore the factors correlated with fatigue and anorexia in patients with advanced cancer at palliative care unit
Date of disclosure of the study information 2017/02/20
Last modified on 2020/02/22 11:54:44

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The study to explore the factors correlated with fatigue and anorexia in patients with advanced cancer at palliative care unit

Acronym

The exploration for the factors correlated with cancer-related fatigue or anorexia

Scientific Title

The study to explore the factors correlated with fatigue and anorexia in patients with advanced cancer at palliative care unit

Scientific Title:Acronym

The exploration for the factors correlated with cancer-related fatigue or anorexia

Region

Japan


Condition

Condition

Solid tumor
(Exclude: breast cacner, prostate cancer, renal cell carcinoma, hematologic tumor)

Classification by specialty

Medicine in general Adult

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To explore the factors correlated with fatigue and anorexia in patients with advanced cancer at palliative care uni

Basic objectives2

Others

Basic objectives -Others

the correlation between fatigue/anorexia and other factors

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

carnitine

Key secondary outcomes

inventory of fatigue/anorexia, cytokines, mRNA of PBMC, fecus


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who are
1) advanced cancer diagnosed by clinical or pathological investigation
2) in palliative care unit at national cancer center hospital east
3) more than 20 years old
4) able to understand Japanese

Key exclusion criteria

Patients who are
1) breast cancer, prostate cancer, renal cell carcinoma and hematologic tumors
2) in a disturbance of consciousness (positive for confusion assessment method)
3) administered with corticosteroid within a week.
4) severe physical symptoms or distress

Target sample size

45


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Tomofumi Miura

Organization

National Cancer Center Hospital East

Division name

Division of Palliative Medicine

Zip code


Address

Kashiwanoha 6-5-1, Kashiwa, Chiba, Japan

TEL

04-7133-1111

Email

tomiura@east.ncc.go.jp


Public contact

Name of contact person

1st name
Middle name
Last name Tomofumi Miura

Organization

National Cancer Center Hospital East

Division name

Division of Palliative Medicine

Zip code


Address

Kashiwanoha 6-5-1, Kashiwa, Chiba, Japan

TEL

04-7133-1111

Homepage URL


Email

tomiura@east.ncc.go.jp


Sponsor or person

Institute

National Cancer Center Hospital East

Institute

Department

Personal name



Funding Source

Organization

National Cancer Center Hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 02 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 12 Month 12 Day

Date of IRB

2016 Year 12 Month 12 Day

Anticipated trial start date

2016 Year 12 Month 20 Day

Last follow-up date

2019 Year 02 Month 20 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This study has been completed


Management information

Registered date

2017 Year 02 Month 19 Day

Last modified on

2020 Year 02 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030114


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name